Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Bont

Showing results (141-150 of 174) with videos related to

Pageof 18
Sort By:
The Journal of Infectious Diseases|August 19, 2007
Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genesRiny Janssen, Louis Bont, Christine L E Siezen, et al.
Clinical and Translational Medicine|December 20, 2023
Single-cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infantsNevena Zivanovic, Deniz Öner, Yann Abraham, et al.
The Journal of Infectious Diseases|July 28, 2022
Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus InfectionJoseph P McGinley, Gu Lung Lin, Deniz Öner, et al.
Molecular Nutrition & Food Research|June 30, 2025
Maternal Dietary Fiber Intake During Lactation and Human Milk Oligosaccharide Fucosylation: a PRIMA Birth Cohort StudyAnneke H Hellinga, Samanta Cajic, Hanneke F Linde, et al.
Vaccine|March 20, 2023
Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in EuropeZhuxin Mao, Xiao Li, Ana Dacosta-Urbieta, et al.
Vaccine|February 3, 2023
Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countriesAbraham M Getaneh, Xiao Li, Zhuxin Mao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2016
Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection With Viral Coinfection in HIV-Uninfected ChildrenNatalie I Mazur, Louis Bont, Adam L Cohen, et al.
Frontiers in Immunology|November 8, 2023
T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adultsBruno Salaun, Jonathan De Smedt, Charlotte Vernhes, et al.
The European Respiratory Journal|October 16, 2020
Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort studyKoos Korsten, Niels Adriaenssens, Samuel Coenen, et al.
Contemporary Clinical Trials|July 2, 2025
Evaluation of a monoclonal antibody against respiratory syncytial virus, Clesrovimab, in infants and children: Comprehensive rationale and study design for the late-stage clinical trialsAnushua Sinha, Radha A Railkar, Luis Castagnini, et al.
Pageof 18

Showing results (141-150 of 174) with videos related to

Sort By:
Pageof 18
The Journal of Infectious Diseases|August 19, 2007
Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genesRiny Janssen, Louis Bont, Christine L E Siezen, et al.
Clinical and Translational Medicine|December 20, 2023
Single-cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infantsNevena Zivanovic, Deniz Öner, Yann Abraham, et al.
The Journal of Infectious Diseases|July 28, 2022
Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus InfectionJoseph P McGinley, Gu Lung Lin, Deniz Öner, et al.
Molecular Nutrition & Food Research|June 30, 2025
Maternal Dietary Fiber Intake During Lactation and Human Milk Oligosaccharide Fucosylation: a PRIMA Birth Cohort StudyAnneke H Hellinga, Samanta Cajic, Hanneke F Linde, et al.
Vaccine|March 20, 2023
Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in EuropeZhuxin Mao, Xiao Li, Ana Dacosta-Urbieta, et al.
Vaccine|February 3, 2023
Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countriesAbraham M Getaneh, Xiao Li, Zhuxin Mao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2016
Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection With Viral Coinfection in HIV-Uninfected ChildrenNatalie I Mazur, Louis Bont, Adam L Cohen, et al.
Frontiers in Immunology|November 8, 2023
T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adultsBruno Salaun, Jonathan De Smedt, Charlotte Vernhes, et al.
The European Respiratory Journal|October 16, 2020
Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort studyKoos Korsten, Niels Adriaenssens, Samuel Coenen, et al.
Contemporary Clinical Trials|July 2, 2025
Evaluation of a monoclonal antibody against respiratory syncytial virus, Clesrovimab, in infants and children: Comprehensive rationale and study design for the late-stage clinical trialsAnushua Sinha, Radha A Railkar, Luis Castagnini, et al.
Pageof 18